Results 131 to 140 of about 33,909 (239)
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis
Background/Objectives: Antibody light chains form amyloid fibrils that lead to progressive tissue damage in amyloid light chain (AL) amyloidosis. The properties of each patient’s unique light chain appear to determine its propensity to form amyloid.
Gareth J. Morgan +4 more
doaj +1 more source
ABSTRACT Background and Aims Monoclonal gammopathy of undetermined significance (MGUS) occurs in some patients with chronic inflammatory demyelinating polyneuropathy (CIDP), but its impact on clinical phenotype and treatment response remains unclear.
R. van Veen +16 more
wiley +1 more source
An unusual case of multiple myeloma [PDF]
The case concerns the unusual presentation of a non-secretory multiple myeloma with diarrhoea secondary to large bowel infiltration. In December 2009, a 74-year-old lady presented to hospital and complained of a two year history of intermittent ...
Delicata, Julian, Farrugia, Daniel
core
Shayna Sarosiek, Vaishali Sanchorawala Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USACorrespondence: Shayna Sarosiek; Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and ...
Sarosiek S, Sanchorawala V
doaj
Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation. [PDF]
Molecular tweezers (MTs) are supramolecular host molecules equipped with two aromatic pincers linked together by a spacer (Gakh, 2018). They are endowed with fascinating properties originating from their ability to hold guests between their aromatic ...
Bitan, Gal +4 more
core
A Case of Amyloid Light-Chain Amyloidosis Presenting as Colitis. [PDF]
Prabakaran K +7 more
europepmc +1 more source
Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients. [PDF]
Song L +9 more
europepmc +1 more source
Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis. [PDF]
Ye Y +5 more
europepmc +1 more source
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis. [PDF]
Shragai T +7 more
europepmc +1 more source
Outcomes of patients with systemic light chain amyloidosis treated with DVD front-line therapy. [PDF]
Wang J +11 more
europepmc +1 more source

